Achieve Life Sciences (ACHV) was given a new $13.00 price target by Canaccord Genuity Group Inc..
Achieve Life Sciences Launches Up to $354 Million Private Placement; Names Andrew Goldberg CEO; Shares Rise [Yahoo! Finance]
Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors
Achieve Life Sciences Announces Up to $354 Million Private Placement
Achieve Life Sciences (ACHV) had its "buy" rating reaffirmed by HC Wainwright. They now have a $12.00 price target on the stock.